CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $47,731
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-04 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −500 | 56,024 | ||
| 2022-01-03 | Scanlan Sean F. SVP, Marketing | Exercise or conversion | +1,000 | $1.57 | $2K | 1,000 |
| 2022-01-03 | Scanlan Sean F. SVP, Marketing | Sale | −1,000 | $20.02 | $20K | 0 |
| 2022-01-03 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 56,524 | ||
| 2021-12-29 | Treace John T. Chief Executive Officer | Sale | −3,075 | $17.01 | $52K | 5,422,580 |
| 2021-12-28 | Treace John T. Chief Executive Officer | Sale | −19,760 | $16.99 | $336K | 5,425,655 |
| 2021-12-28 | TREACE JAMES T Director | Sale | −1,563 | $16.88 | $26K | 2 |
| 2021-12-27 | Treace John T. Chief Executive Officer | Sale | −17,165 | $17.44 | $299K | 5,445,415 |
| 2021-12-27 | TREACE JAMES T Director | Sale | −6,437 | $17.46 | $112K | 1,565 |
| 2021-12-23 | Treace John T. Chief Executive Officer | Sale | −22,795 | $16.96 | $387K | 5,462,580 |
| 2021-12-23 | TREACE JAMES T Director | Sale | −12,610 | $16.90 | $213K | 8,002 |
| 2021-12-22 | Treace John T. Chief Executive Officer | Sale | −41,710 | $16.29 | $679K | 5,485,375 |
| 2021-12-22 | TREACE JAMES T Director | Sale | −23,390 | $16.28 | $381K | 20,612 |
| 2021-12-21 | Treace John T. Chief Executive Officer | Sale | −34,047 | $16.09 | $548K | 5,530,622 |
| 2021-12-21 | Treace John T. Chief Executive Officer | Sale | −3,537 | $16.37 | $58K | 5,527,085 |
| 2021-12-21 | TREACE JAMES T Director | Sale | −13,478 | $16.12 | $217K | 45,405 |
| 2021-12-21 | TREACE JAMES T Director | Sale | −1,403 | $16.36 | $23K | 44,002 |
| 2021-12-20 | Treace John T. Chief Executive Officer | Sale | −22,311 | $15.74 | $351K | 5,565,269 |
| 2021-12-20 | Treace John T. Chief Executive Officer | Sale | −600 | $16.31 | $10K | 5,564,669 |
| 2021-12-20 | TREACE JAMES T Director | Sale | −15,719 | $15.69 | $247K | 1,413,227 |
Page 23 of 28 · 560 trades